Paracetamol Injection Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Paracetamol Injection Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Insights into the Paracetamol Injection Market include supply chain optimization, Paracetamol Injection challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Paracetamol Injection study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Paracetamol Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Paracetamol Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Paracetamol Injection companies in 2021 (%)
The global Paracetamol Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paracetamol Injection include AdvaCare Pharma, DMS Chemical, Johnson & Johnson, Shijiazhuang No. 4 Pharmaceutical Co., Ltd., Sriya Life Science, Anhui Medipharm Co., Ltd., Reyoung Pharmaceutical Co., Ltd., Hebei Lishang Hechuang Sign Co., Ltd and Guangzhou Mandison Biotechnology Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Paracetamol Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Paracetamol Injection Market, by Specification, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, by Specification, 2021 (%)
10 mg/ml
120 mg/ml
150 mg/ml
Others
Global Paracetamol Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Paracetamol Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paracetamol Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paracetamol Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Paracetamol Injection revenues share in global market, 2021 (%)
Key companies Paracetamol Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Paracetamol Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AdvaCare Pharma
DMS Chemical
Johnson & Johnson
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Sriya Life Science
Anhui Medipharm Co., Ltd.
Reyoung Pharmaceutical Co., Ltd.
Hebei Lishang Hechuang Sign Co., Ltd
Guangzhou Mandison Biotechnology Co., Ltd.
Xian Medihealth Company Ltd
Naman Pharma Drugs
Nanjing Sino Pharmaceutical Ltd.
WAMIN
Wellona Pharma
Hebei Tianyuan Pharmaceutical Co., Ltd.
B. Braun
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Paracetamol Injection Market Definition
1.2 Market Segments
1.2.1 Market by Specification
1.2.2 Market by Application
1.3 Global Paracetamol Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Paracetamol Injection Overall Market Size
2.1 Global Paracetamol Injection Market Size: 2021 VS 2028
2.2 Global Paracetamol Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Paracetamol Injection Sales: 2017-2028
3 Company Landscape
3.1 Top Paracetamol Injection Players in Global Market
3.2 Top Global Paracetamol Injection Companies Ranked by Revenue
3.3 Global Paracetamol Injection Revenue by Companies
3.4 Global Paracetamol Injection Sales by Companies
3.5 Global Paracetamol Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Paracetamol Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Paracetamol Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paracetamol Injection Players in Global Market
3.8.1 List of Global Tier 1 Paracetamol Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Paracetamol Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Specification - Global Paracetamol Injection Market Size Markets, 2021 & 2028
4.1.2 10 mg/ml
4.1.3 120 mg/ml
4.1.4 150 mg/ml
4.1.5 Others
4.2 By Specification - Global Paracetamol Injection Revenue & Forecasts
4.2.1 By Specification - Global Paracetamol Injection Revenue, 2017-2022
4.2.2 By Specification - Global Paracetamol Injection Revenue, 2023-2028
4.2.3 By Specification - Global Paracetamol Injection Revenue Market Share, 2017-2028
4.3 By Specification - Global Paracetamol Injection Sales & Forecasts
4.3.1 By Specification - Global Paracetamol Injection Sales, 2017-2022
4.3.2 By Specification - Global Paracetamol Injection Sales, 2023-2028
4.3.3 By Specification - Global Paracetamol Injection Sales Market Share, 2017-2028
4.4 By Specification - Global Paracetamol Injection Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Paracetamol Injection Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Paracetamol Injection Revenue & Forecasts
5.2.1 By Application - Global Paracetamol Injection Revenue, 2017-2022
5.2.2 By Application - Global Paracetamol Injection Revenue, 2023-2028
5.2.3 By Application - Global Paracetamol Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Paracetamol Injection Sales & Forecasts
5.3.1 By Application - Global Paracetamol Injection Sales, 2017-2022
5.3.2 By Application - Global Paracetamol Injection Sales, 2023-2028
5.3.3 By Application - Global Paracetamol Injection Sales Market Share, 2017-2028
5.4 By Application - Global Paracetamol Injection Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Paracetamol Injection Market Size, 2021 & 2028
6.2 By Region - Global Paracetamol Injection Revenue & Forecasts
6.2.1 By Region - Global Paracetamol Injection Revenue, 2017-2022
6.2.2 By Region - Global Paracetamol Injection Revenue, 2023-2028
6.2.3 By Region - Global Paracetamol Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Paracetamol Injection Sales & Forecasts
6.3.1 By Region - Global Paracetamol Injection Sales, 2017-2022
6.3.2 By Region - Global Paracetamol Injection Sales, 2023-2028
6.3.3 By Region - Global Paracetamol Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Paracetamol Injection Revenue, 2017-2028
6.4.2 By Country - North America Paracetamol Injection Sales, 2017-2028
6.4.3 US Paracetamol Injection Market Size, 2017-2028
6.4.4 Canada Paracetamol Injection Market Size, 2017-2028
6.4.5 Mexico Paracetamol Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Paracetamol Injection Revenue, 2017-2028
6.5.2 By Country - Europe Paracetamol Injection Sales, 2017-2028
6.5.3 Germany Paracetamol Injection Market Size, 2017-2028
6.5.4 France Paracetamol Injection Market Size, 2017-2028
6.5.5 U.K. Paracetamol Injection Market Size, 2017-2028
6.5.6 Italy Paracetamol Injection Market Size, 2017-2028
6.5.7 Russia Paracetamol Injection Market Size, 2017-2028
6.5.8 Nordic Countries Paracetamol Injection Market Size, 2017-2028
6.5.9 Benelux Paracetamol Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Paracetamol Injection Revenue, 2017-2028
6.6.2 By Region - Asia Paracetamol Injection Sales, 2017-2028
6.6.3 China Paracetamol Injection Market Size, 2017-2028
6.6.4 Japan Paracetamol Injection Market Size, 2017-2028
6.6.5 South Korea Paracetamol Injection Market Size, 2017-2028
6.6.6 Southeast Asia Paracetamol Injection Market Size, 2017-2028
6.6.7 India Paracetamol Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Paracetamol Injection Revenue, 2017-2028
6.7.2 By Country - South America Paracetamol Injection Sales, 2017-2028
6.7.3 Brazil Paracetamol Injection Market Size, 2017-2028
6.7.4 Argentina Paracetamol Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Paracetamol Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Paracetamol Injection Sales, 2017-2028
6.8.3 Turkey Paracetamol Injection Market Size, 2017-2028
6.8.4 Israel Paracetamol Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Paracetamol Injection Market Size, 2017-2028
6.8.6 UAE Paracetamol Injection Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AdvaCare Pharma
7.1.1 AdvaCare Pharma Corporate Summary
7.1.2 AdvaCare Pharma Business Overview
7.1.3 AdvaCare Pharma Paracetamol Injection Major Product Offerings
7.1.4 AdvaCare Pharma Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.1.5 AdvaCare Pharma Key News
7.2 DMS Chemical
7.2.1 DMS Chemical Corporate Summary
7.2.2 DMS Chemical Business Overview
7.2.3 DMS Chemical Paracetamol Injection Major Product Offerings
7.2.4 DMS Chemical Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.2.5 DMS Chemical Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Paracetamol Injection Major Product Offerings
7.3.4 Johnson & Johnson Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
7.4.1 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Corporate Summary
7.4.2 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Business Overview
7.4.3 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Paracetamol Injection Major Product Offerings
7.4.4 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.4.5 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Key News
7.5 Sriya Life Science
7.5.1 Sriya Life Science Corporate Summary
7.5.2 Sriya Life Science Business Overview
7.5.3 Sriya Life Science Paracetamol Injection Major Product Offerings
7.5.4 Sriya Life Science Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.5.5 Sriya Life Science Key News
7.6 Anhui Medipharm Co., Ltd.
7.6.1 Anhui Medipharm Co., Ltd. Corporate Summary
7.6.2 Anhui Medipharm Co., Ltd. Business Overview
7.6.3 Anhui Medipharm Co., Ltd. Paracetamol Injection Major Product Offerings
7.6.4 Anhui Medipharm Co., Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.6.5 Anhui Medipharm Co., Ltd. Key News
7.7 Reyoung Pharmaceutical Co., Ltd.
7.7.1 Reyoung Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Reyoung Pharmaceutical Co., Ltd. Business Overview
7.7.3 Reyoung Pharmaceutical Co., Ltd. Paracetamol Injection Major Product Offerings
7.7.4 Reyoung Pharmaceutical Co., Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.7.5 Reyoung Pharmaceutical Co., Ltd. Key News
7.8 Hebei Lishang Hechuang Sign Co., Ltd
7.8.1 Hebei Lishang Hechuang Sign Co., Ltd Corporate Summary
7.8.2 Hebei Lishang Hechuang Sign Co., Ltd Business Overview
7.8.3 Hebei Lishang Hechuang Sign Co., Ltd Paracetamol Injection Major Product Offerings
7.8.4 Hebei Lishang Hechuang Sign Co., Ltd Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.8.5 Hebei Lishang Hechuang Sign Co., Ltd Key News
7.9 Guangzhou Mandison Biotechnology Co., Ltd.
7.9.1 Guangzhou Mandison Biotechnology Co., Ltd. Corporate Summary
7.9.2 Guangzhou Mandison Biotechnology Co., Ltd. Business Overview
7.9.3 Guangzhou Mandison Biotechnology Co., Ltd. Paracetamol Injection Major Product Offerings
7.9.4 Guangzhou Mandison Biotechnology Co., Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.9.5 Guangzhou Mandison Biotechnology Co., Ltd. Key News
7.10 Xian Medihealth Company Ltd
7.10.1 Xian Medihealth Company Ltd Corporate Summary
7.10.2 Xian Medihealth Company Ltd Business Overview
7.10.3 Xian Medihealth Company Ltd Paracetamol Injection Major Product Offerings
7.10.4 Xian Medihealth Company Ltd Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.10.5 Xian Medihealth Company Ltd Key News
7.11 Naman Pharma Drugs
7.11.1 Naman Pharma Drugs Corporate Summary
7.11.2 Naman Pharma Drugs Paracetamol Injection Business Overview
7.11.3 Naman Pharma Drugs Paracetamol Injection Major Product Offerings
7.11.4 Naman Pharma Drugs Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.11.5 Naman Pharma Drugs Key News
7.12 Nanjing Sino Pharmaceutical Ltd.
7.12.1 Nanjing Sino Pharmaceutical Ltd. Corporate Summary
7.12.2 Nanjing Sino Pharmaceutical Ltd. Paracetamol Injection Business Overview
7.12.3 Nanjing Sino Pharmaceutical Ltd. Paracetamol Injection Major Product Offerings
7.12.4 Nanjing Sino Pharmaceutical Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.12.5 Nanjing Sino Pharmaceutical Ltd. Key News
7.13 WAMIN
7.13.1 WAMIN Corporate Summary
7.13.2 WAMIN Paracetamol Injection Business Overview
7.13.3 WAMIN Paracetamol Injection Major Product Offerings
7.13.4 WAMIN Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.13.5 WAMIN Key News
7.14 Wellona Pharma
7.14.1 Wellona Pharma Corporate Summary
7.14.2 Wellona Pharma Business Overview
7.14.3 Wellona Pharma Paracetamol Injection Major Product Offerings
7.14.4 Wellona Pharma Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.14.5 Wellona Pharma Key News
7.15 Hebei Tianyuan Pharmaceutical Co., Ltd.
7.15.1 Hebei Tianyuan Pharmaceutical Co., Ltd. Corporate Summary
7.15.2 Hebei Tianyuan Pharmaceutical Co., Ltd. Business Overview
7.15.3 Hebei Tianyuan Pharmaceutical Co., Ltd. Paracetamol Injection Major Product Offerings
7.15.4 Hebei Tianyuan Pharmaceutical Co., Ltd. Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.15.5 Hebei Tianyuan Pharmaceutical Co., Ltd. Key News
7.16 B. Braun
7.16.1 B. Braun Corporate Summary
7.16.2 B. Braun Business Overview
7.16.3 B. Braun Paracetamol Injection Major Product Offerings
7.16.4 B. Braun Paracetamol Injection Sales and Revenue in Global (2017-2022)
7.16.5 B. Braun Key News
8 Global Paracetamol Injection Production Capacity, Analysis
8.1 Global Paracetamol Injection Production Capacity, 2017-2028
8.2 Paracetamol Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Paracetamol Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Paracetamol Injection Supply Chain Analysis
10.1 Paracetamol Injection Industry Value Chain
10.2 Paracetamol Injection Upstream Market
10.3 Paracetamol Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Paracetamol Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Paracetamol Injection Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|